ElMindA is a brain-tech company addressing the challenge of understanding the human brain, paving a path for better brain health.
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 16, 2015 | Series C | $28M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
OurCrowd | — | Series C |
QB1 Ventures | — | Series C |